Stay updated on Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial
Sign up to get notified when there's something new on the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page.

Latest updates to the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page
- Check3 days agoChange DetectedRecruitment status updated to no longer looking for participants, and the revision history now shows a new version (v3.6.0) replacing the previous v3.5.5.SummaryDifference0.3%

- Check10 days agoChange DetectedA new revision entry labeled Revision: v3.5.5 has been added to the history, replacing the prior Revision: v3.5.4. This change updates the study record's history metadata on the Record History page.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe release notes now reflect the site version as v3.5.4, replacing the prior v3.5.3.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page’s footer version/revision label has been updated from 3.5.2 to 3.5.3, reflecting a maintenance/release update with no apparent change to the study’s recorded information.SummaryDifference0.1%

- Check60 days agoChange DetectedAdded a new revision entry (v3.5.2) and removed an older revision (v3.5.0) in the study record history; this is a metadata version update rather than a change to the study data.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed on the Record History page, indicating a software update to the history tracking system.SummaryDifference0.1%

Stay in the know with updates to Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bosutinib + Inotuzumab in CD22+ ALL/CML Clinical Trial page.